3,095 results on '"Leung, Nelson"'
Search Results
2. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management
3. Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases
4. Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
5. Assessment of Glomerular Filtration Rate in Patients with Cancer: A Statement from the American Society of Onco-Nephrology
6. Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies – Perspectives from the ASON
7. Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
8. Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis
9. Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100
10. Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
11. Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study
12. Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies
13. 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review
14. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
15. Multimode photon blockade
16. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
17. Monoclonal immunoglobulin crystalline nephropathies
18. Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis
19. Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
20. Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
21. Multiple myeloma with acute light chain cast nephropathy
22. Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma
23. Glomerulonephritis: immunopathogenesis and immunotherapy
24. Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis
25. A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis
26. Clonal monocytosis of renal significance
27. Clinicopathologic Characteristics of Crystalglobulin-Induced Nephropathy: A Case Series
28. Kidney Transplantation in Multiple Myeloma and Monoclonal Gammopathy of Renal Significance
29. Multimode photon blockade
30. Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas
31. Primary Total Hip Arthroplasty in Dialysis-Dependent Patients: 35% Mortality at 5 years
32. Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment
33. Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy
34. Partial Compilation of Variational Algorithms for Noisy Intermediate-Scale Quantum Machines
35. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
36. Optimized Compilation of Aggregated Instructions for Realistic Quantum Computers
37. Outcomes after biochemical or clinical progression in patients with multiple myeloma
38. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors
39. Pathological characteristics of light chain crystalline podocytopathy
40. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review
41. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
42. First relapse in patients with multiple myeloma: Outcomes and predictors.
43. A Dissipatively Stabilized Mott Insulator of Photons
44. Applications of disruptive digital technologies in hotel industry: A systematic review
45. Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
46. The characteristics of seronegative and seropositive non-hepatitis-associated cryoglobulinemic glomerulonephritis
47. Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning
48. Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy
49. Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
50. Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.